Shanghai Labway Clinical Laboratory Co., Ltd Stock: price and insider trades · China
兰卫医学
Shanghai Labway Clinical Laboratory Co., Ltd: what insiders have been doing
Shanghai Labway Clinical Laboratory Co., Ltd belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). The past year has been quiet: not a single insider filing for Shanghai Labway Clinical Laboratory Co., Ltd. The previous disclosure was published on 26 March 2024.
Since 2022, the database holds no purchases and 3 sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Shanghai Labway Clinical Laboratory Co., Ltd
兰卫医学 is a company focused on the healthcare and pharmaceutical sector, providing innovative solutions for diagnosis and treatment. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
